Last reviewed · How we verify
dehydroepiandrosterone crystalline fine powder — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
dehydroepiandrosterone crystalline fine powder (dehydroepiandrosterone crystalline fine powder) — Meir Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| dehydroepiandrosterone crystalline fine powder TARGET | dehydroepiandrosterone crystalline fine powder | Meir Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- dehydroepiandrosterone crystalline fine powder CI watch — RSS
- dehydroepiandrosterone crystalline fine powder CI watch — Atom
- dehydroepiandrosterone crystalline fine powder CI watch — JSON
- dehydroepiandrosterone crystalline fine powder alone — RSS
Cite this brief
Drug Landscape (2026). dehydroepiandrosterone crystalline fine powder — Competitive Intelligence Brief. https://druglandscape.com/ci/dehydroepiandrosterone-crystalline-fine-powder. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab